Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. … Read more
Plant Advanced Technologies SA (ALPAT) - Net Assets
Latest net assets as of June 2025: €9.11 Million EUR
Based on the latest financial reports, Plant Advanced Technologies SA (ALPAT) has net assets worth €9.11 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€15.59 Million) and total liabilities (€6.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €9.11 Million |
| % of Total Assets | 58.43% |
| Annual Growth Rate | 28.68% |
| 5-Year Change | 7.33% |
| 10-Year Change | 118737.76% |
| Growth Volatility | 28919.13 |
Plant Advanced Technologies SA - Net Assets Trend (2008–2024)
This chart illustrates how Plant Advanced Technologies SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Plant Advanced Technologies SA (2008–2024)
The table below shows the annual net assets of Plant Advanced Technologies SA from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €9.17 Million | +12.74% |
| 2023-12-31 | €8.13 Million | +19.78% |
| 2022-12-31 | €6.79 Million | -8.03% |
| 2021-12-31 | €7.38 Million | -13.57% |
| 2020-12-31 | €8.54 Million | -14.62% |
| 2019-12-31 | €10.00 Million | +119514.41% |
| 2018-12-31 | €8.36K | +30.48% |
| 2017-12-31 | €6.41K | -2.72% |
| 2016-12-31 | €6.59K | -14.59% |
| 2015-12-31 | €7.71K | +227.58% |
| 2014-12-31 | €2.35K | -99.89% |
| 2013-12-31 | €2.10 Million | -2.60% |
| 2012-12-31 | €2.15 Million | +3.64% |
| 2011-12-31 | €2.08 Million | -7.58% |
| 2010-12-31 | €2.25 Million | +292.93% |
| 2009-12-31 | €571.54K | +252.19% |
| 2008-12-31 | €162.28K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Plant Advanced Technologies SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 205673.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €1.11 Million | 12.15% |
| Other Components | €12.01 Million | 130.98% |
| Total Equity | €9.17 Million | 100.00% |
Plant Advanced Technologies SA Competitors by Market Cap
The table below lists competitors of Plant Advanced Technologies SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bhandari Hosiery Exports Limited
NSE:BHANDARI
|
$4.21 Million |
|
PT Solusi Bangun Indonesia Tbk
F:RU6
|
$4.21 Million |
|
Taiga Motors Corporation
PINK:TAIMF
|
$4.21 Million |
|
Cruz Cobalt Corp
PINK:BKTPF
|
$4.21 Million |
|
CirChem AB
ST:CIRCHE
|
$4.20 Million |
|
PMVCD
PINK:PMVCD
|
$4.20 Million |
|
New Concept Energy Inc
NYSE MKT:GBR
|
$4.20 Million |
|
Entre Cua Socimi
MC:YENT
|
$4.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Plant Advanced Technologies SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,130,573 to 9,166,206, a change of 1,035,633 (12.7%).
- Net income of 935,126 contributed positively to equity growth.
- Share repurchases of 106,840 reduced equity.
- New share issuances of 106,840 increased equity.
- Other factors increased equity by 100,507.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €935.13K | +10.2% |
| Share Repurchases | €106.84K | -1.17% |
| Share Issuances | €106.84K | +1.17% |
| Other Changes | €100.51K | +1.1% |
| Total Change | €- | 12.74% |
Book Value vs Market Value Analysis
This analysis compares Plant Advanced Technologies SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.81x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.27x to 0.81x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | €2.95 | €6.70 | x |
| 2012-12-31 | €2.19 | €6.70 | x |
| 2013-12-31 | €3.49 | €6.70 | x |
| 2014-12-31 | €0.00 | €6.70 | x |
| 2015-12-31 | €0.01 | €6.70 | x |
| 2016-12-31 | €0.01 | €6.70 | x |
| 2017-12-31 | €0.01 | €6.70 | x |
| 2018-12-31 | €0.01 | €6.70 | x |
| 2019-12-31 | €9.25 | €6.70 | x |
| 2020-12-31 | €6.96 | €6.70 | x |
| 2021-12-31 | €5.86 | €6.70 | x |
| 2022-12-31 | €5.06 | €6.70 | x |
| 2023-12-31 | €7.19 | €6.70 | x |
| 2024-12-31 | €8.25 | €6.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Plant Advanced Technologies SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.20%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 48.52%
- • Asset Turnover: 0.12x
- • Equity Multiplier: 1.75x
- Recent ROE (10.20%) is above the historical average (-5.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 1.18% | 2.25% | 0.16x | 3.27x | €-14.31K |
| 2009 | -7.69% | -45.77% | 0.09x | 1.79x | €-101.10K |
| 2010 | -1.89% | -22.09% | 0.05x | 1.82x | €-210.36K |
| 2011 | 1.44% | 12.11% | 0.07x | 1.60x | €-153.67K |
| 2012 | 12.06% | 28.28% | 0.26x | 1.65x | €44.22K |
| 2013 | -3.15% | -5.47% | 0.28x | 2.03x | €-275.56K |
| 2014 | -25.25% | -35.31% | 0.31x | 2.34x | €-830.09 |
| 2015 | -11.60% | -47.61% | 0.18x | 1.35x | €-1.67K |
| 2016 | -17.08% | -71.36% | 0.16x | 1.49x | €-1.78K |
| 2017 | -10.53% | -46.14% | 0.15x | 1.53x | €-1.32K |
| 2018 | 10.34% | 46.17% | 0.15x | 1.52x | €28.21 |
| 2019 | -5.41% | -46.15% | 0.08x | 1.39x | €-1.54 Million |
| 2020 | -7.21% | -31.59% | 0.10x | 2.29x | €-1.30 Million |
| 2021 | -17.84% | -49.20% | 0.13x | 2.69x | €-1.77 Million |
| 2022 | -15.42% | -36.30% | 0.14x | 3.10x | €-1.40 Million |
| 2023 | 0.97% | 4.71% | 0.11x | 1.83x | €-733.89K |
| 2024 | 10.20% | 48.52% | 0.12x | 1.75x | €18.51K |
Industry Comparison
This section compares Plant Advanced Technologies SA's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $11,397,324
- Average return on equity (ROE) among peers: -51.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Plant Advanced Technologies SA (ALPAT) | €9.11 Million | 1.18% | 0.71x | $4.20 Million |
| Abionyx Pharma SA (ABNX) | $8.89 Million | -56.01% | 1.06x | $72.33 Million |
| Abivax SA (ABVX) | $56.72 Million | -25.23% | 0.07x | $3.97 Billion |
| Adocia (ADOC) | $-6.91 Million | 0.00% | 0.00x | $84.57 Million |
| Aelis Farma SA (AELIS) | $898.00K | 63.92% | 30.53x | $5.01 Million |
| Acticor Biotech SAS (ALACT) | $-4.04 Million | 0.00% | 0.00x | $2.13 Million |
| NicOx S.A. (ALCOX) | $21.41 Million | -97.51% | 1.47x | $28.49 Million |
| Advicenne (ALDVI) | $-1.67 Million | 0.00% | 0.00x | $15.84 Million |
| ALGAE (ALGAE) | $32.76 Million | -39.31% | 0.56x | $29.13 Million |
| Genoway (ALGEN) | $5.23 Million | 9.60% | 1.10x | $23.45K |
| Integragen (ALINT) | $691.87K | -367.93% | 7.36x | $424.10K |